in this issue
Regions :: Western Europe
Novasep Expands Its HPAPI Manufacturing Facility in France
11:32 AM MDT | July 19, 2012 | Sotirios Frantzanas
Novasep (Pompey, France) says it will expand its highly potent active pharmaceutical ingredients (HPAPI) manufacturing capabilities at the company's Le Mans, France facility. The amount of the investment is €3 million ($3.7 million), and the plant expansion is expected to be fully operational by the beginning of 2013, the company says. There is a sharp increase in demand for "targeted and potent" drugs that improve efficacy and reduce side effects, such as antibody-drug conjugates (ADC), Novasep says. The expansion of Novasep's Le Mans...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee